25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Shanghai Yizhong Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyze Shanghai Yizhong Pharmaceutical Co Ltd together

I guess you are interested in Shanghai Yizhong Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Yizhong Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shanghai Yizhong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shanghai Yizhong Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Shanghai Yizhong Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Shanghai Yizhong Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
52.6%

What is your share worth?

Current worth
¥6.96
Expected worth in 1 year
¥7.00
How sure are you?
68.4%

+ What do you gain per year?

Total Gains per Share
¥0.29
Return On Investment
0.7%

For what price can you sell your share?

Current Price per Share
¥40.98
Expected price per share
¥33.34 - ¥50.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shanghai Yizhong Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥40.98
Intrinsic Value Per Share
¥-1.85 - ¥-2.22
Total Value Per Share
¥5.11 - ¥4.74

2.2. Growth of Shanghai Yizhong Pharmaceutical Co Ltd (5 min.)




Is Shanghai Yizhong Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$197.3m$189.4m$11.6m5.8%

How much money is Shanghai Yizhong Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.2m$5.8m-$3.5m-158.1%
Net Profit Margin22.7%48.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Shanghai Yizhong Pharmaceutical Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shanghai Yizhong Pharmaceutical Co Ltd?

Welcome investor! Shanghai Yizhong Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Shanghai Yizhong Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Shanghai Yizhong Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Yizhong Pharmaceutical Co Ltd is ¥40.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Yizhong Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Yizhong Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.96. Based on the TTM, the Book Value Change Per Share is ¥0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Yizhong Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.010.0%0.030.1%0.010.0%0.010.0%
Usd Book Value Change Per Share-0.020.0%0.000.0%0.020.1%0.050.1%0.050.1%
Usd Dividend Per Share0.000.0%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.020.0%0.010.0%0.020.1%0.050.1%0.050.1%
Usd Price Per Share4.86-5.66-9.98-6.15-6.15-
Price to Earnings Ratio11,350.28-2,937.97-92.10-656.51-656.51-
Price-to-Total Gains Ratio-321.47-182.83-557.21-418.75-418.75-
Price to Book Ratio5.09-5.81-10.90-7.02-7.02-
Price-to-Total Gains Ratio-321.47-182.83-557.21-418.75-418.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.626554
Number of shares177
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.000.05
Usd Total Gains Per Share0.010.05
Gains per Quarter (177 shares)1.769.21
Gains per Year (177 shares)7.0236.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
161-313627
2122437164
3183114107101
4235185142138
5296256178175
6357328214212
7418399249249
84794610285286
953105311320323
1059126013356360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%12.07.00.063.2%12.07.00.063.2%12.07.00.063.2%
Book Value Change Per Share2.02.00.050.0%10.02.00.083.3%12.05.02.063.2%12.05.02.063.2%12.05.02.063.2%
Dividend per Share4.00.00.0100.0%9.00.03.075.0%10.00.09.052.6%10.00.09.052.6%10.00.09.052.6%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%13.04.02.068.4%13.04.02.068.4%13.04.02.068.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shanghai Yizhong Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1110.012-1026%0.179-162%0.366-130%0.366-130%
Book Value Per Share--6.9577.093-2%6.681+4%4.823+44%4.823+44%
Current Ratio--18.01114.332+26%30.081-40%28.515-37%28.515-37%
Debt To Asset Ratio--0.0340.056-39%0.038-9%0.046-25%0.046-25%
Debt To Equity Ratio--0.0350.060-41%0.039-10%0.049-27%0.049-27%
Dividend Per Share--0.0010.060-99%0.001+7%0.013-96%0.013-96%
Enterprise Value--7266483719.7408427144207.635-14%15235578656.112-52%13917774790.183-48%13917774790.183-48%
Eps--0.0010.079-99%0.205-100%0.080-99%0.080-99%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--38.09532.976+16%44.334-14%infnan%infnan%
Free Cash Flow Per Share---0.095-0.010-90%0.037-355%-0.020-79%-0.020-79%
Free Cash Flow To Equity Per Share---0.095-0.010-90%0.037-355%0.217-144%0.217-144%
Gross Profit Margin--1.0001.0000%0.933+7%0.901+11%0.901+11%
Intrinsic Value_10Y_max---2.219--------
Intrinsic Value_10Y_min---1.847--------
Intrinsic Value_1Y_max---0.045--------
Intrinsic Value_1Y_min---0.044--------
Intrinsic Value_3Y_max---0.270--------
Intrinsic Value_3Y_min---0.255--------
Intrinsic Value_5Y_max---0.658--------
Intrinsic Value_5Y_min---0.599--------
Market Cap8466016892.160+14%7317382096.6408515081777.760-14%15017475465.685-51%9247361468.045-21%9247361468.045-21%
Net Profit Margin--0.0030.227-99%0.486-99%3.057-100%3.057-100%
Operating Margin----0%0.179-100%2.187-100%2.187-100%
Operating Ratio--1.2110.896+35%0.554+119%0.246+392%0.246+392%
Pb Ratio5.891+14%5.0915.805-12%10.901-53%7.018-27%7.018-27%
Pe Ratio13131.968+14%11350.2762937.967+286%92.099+12224%656.508+1629%656.508+1629%
Price Per Share40.980+14%35.42041.218-14%72.693-51%44.762-21%44.762-21%
Price To Free Cash Flow Ratio-108.082-16%-93.41828.051-433%49.958-287%-250.028+168%-250.028+168%
Price To Total Gains Ratio-371.928-16%-321.466182.830-276%557.207-158%418.749-177%418.749-177%
Quick Ratio--2.5524.844-47%18.255-86%33.594-92%33.594-92%
Return On Assets--0.0000.010-99%0.030-100%0.006-98%0.006-98%
Return On Equity--0.0000.011-99%0.031-100%0.006-98%0.006-98%
Total Gains Per Share---0.1100.072-253%0.179-162%0.379-129%0.379-129%
Usd Book Value--197325323.497201178597.422-2%189497196.810+4%136803247.720+44%136803247.720+44%
Usd Book Value Change Per Share---0.0150.002-1026%0.025-162%0.050-130%0.050-130%
Usd Book Value Per Share--0.9550.974-2%0.917+4%0.662+44%0.662+44%
Usd Dividend Per Share--0.0000.008-99%0.000+7%0.002-96%0.002-96%
Usd Enterprise Value--997688214.7201157046899.708-14%2091844949.484-52%1910910478.692-48%1910910478.692-48%
Usd Eps--0.0000.011-99%0.028-100%0.011-99%0.011-99%
Usd Free Cash Flow---2688659.118-276319.786-90%1054748.265-355%-562366.278-79%-562366.278-79%
Usd Free Cash Flow Per Share---0.013-0.001-90%0.005-355%-0.003-79%-0.003-79%
Usd Free Cash Flow To Equity Per Share---0.013-0.001-90%0.005-355%0.030-144%0.030-144%
Usd Market Cap1162384119.294+14%1004676561.8691169120728.086-14%2061899381.439-51%1269662729.563-21%1269662729.563-21%
Usd Price Per Share5.627+14%4.8635.659-14%9.981-51%6.146-21%6.146-21%
Usd Profit--22128.9022251724.135-99%5811650.392-100%2260444.734-99%2260444.734-99%
Usd Revenue--6547340.0588603929.415-24%11973758.833-45%5536188.284+18%5536188.284+18%
Usd Total Gains Per Share---0.0150.010-253%0.025-162%0.052-129%0.052-129%
 EOD+4 -4MRQTTM+7 -30YOY+11 -285Y+9 -2910Y+9 -29

3.3 Fundamental Score

Let's check the fundamental score of Shanghai Yizhong Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513,131.968
Price to Book Ratio (EOD)Between0-15.891
Net Profit Margin (MRQ)Greater than00.003
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.552
Current Ratio (MRQ)Greater than118.011
Debt to Asset Ratio (MRQ)Less than10.034
Debt to Equity Ratio (MRQ)Less than10.035
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Shanghai Yizhong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.804
Ma 20Greater thanMa 5036.809
Ma 50Greater thanMa 10037.421
Ma 100Greater thanMa 20039.053
OpenGreater thanClose41.140
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Shanghai Yizhong Pharmaceutical Co Ltd

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also develops paclitaxel polymer micelle for the treatment of non-small cell lung cancer. The company was founded in 2009 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2025-02-15 00:43:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shanghai Yizhong Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.3% means that ¥0.00 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.3%. The company is not making a profit/loss.
  • The TTM is 22.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ0.3%TTM22.7%-22.4%
TTM22.7%YOY48.6%-25.8%
TTM22.7%5Y305.7%-282.9%
5Y305.7%10Y305.7%0.0%
4.3.1.2. Return on Assets

Shows how efficient Shanghai Yizhong Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Shanghai Yizhong Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.0%-1.0%
TTM1.0%YOY3.0%-1.9%
TTM1.0%5Y0.6%+0.4%
5Y0.6%10Y0.6%0.0%
4.3.1.3. Return on Equity

Shows how efficient Shanghai Yizhong Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Shanghai Yizhong Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM1.1%-1.1%
TTM1.1%YOY3.1%-2.0%
TTM1.1%5Y0.6%+0.5%
5Y0.6%10Y0.6%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shanghai Yizhong Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shanghai Yizhong Pharmaceutical Co Ltd is operating .

  • Measures how much profit Shanghai Yizhong Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY17.9%-17.9%
TTM-5Y218.7%-218.7%
5Y218.7%10Y218.7%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Shanghai Yizhong Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are ¥1.21 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 1.211. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.896. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.211TTM0.896+0.315
TTM0.896YOY0.554+0.342
TTM0.8965Y0.246+0.650
5Y0.24610Y0.2460.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shanghai Yizhong Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shanghai Yizhong Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 18.01 means the company has ¥18.01 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 18.011. The company is very able to pay all its short-term debts. +2
  • The TTM is 14.332. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ18.011TTM14.332+3.679
TTM14.332YOY30.081-15.749
TTM14.3325Y28.515-14.184
5Y28.51510Y28.5150.000
4.4.3.2. Quick Ratio

Measures if Shanghai Yizhong Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.55 means the company can pay off ¥2.55 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 2.552. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.844. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.552TTM4.844-2.292
TTM4.844YOY18.255-13.410
TTM4.8445Y33.594-28.750
5Y33.59410Y33.5940.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shanghai Yizhong Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Yizhong Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.03 means that Shanghai Yizhong Pharmaceutical Co Ltd assets are financed with 3.4% credit (debt) and the remaining percentage (100% - 3.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.034. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.056. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.034TTM0.056-0.022
TTM0.056YOY0.038+0.018
TTM0.0565Y0.046+0.010
5Y0.04610Y0.0460.000
4.5.4.2. Debt to Equity Ratio

Measures if Shanghai Yizhong Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 3.5% means that company has ¥0.04 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The MRQ is 0.035. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.060. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.035TTM0.060-0.024
TTM0.060YOY0.039+0.020
TTM0.0605Y0.049+0.011
5Y0.04910Y0.0490.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Yizhong Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shanghai Yizhong Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11,350.28 means the investor is paying ¥11,350.28 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The EOD is 13,131.968. Based on the earnings, the company is expensive. -2
  • The MRQ is 11,350.276. Based on the earnings, the company is expensive. -2
  • The TTM is 2,937.967. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD13,131.968MRQ11,350.276+1,781.692
MRQ11,350.276TTM2,937.967+8,412.309
TTM2,937.967YOY92.099+2,845.868
TTM2,937.9675Y656.508+2,281.458
5Y656.50810Y656.5080.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The EOD is -108.082. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -93.418. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 28.051. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-108.082MRQ-93.418-14.664
MRQ-93.418TTM28.051-121.469
TTM28.051YOY49.958-21.907
TTM28.0515Y-250.028+278.079
5Y-250.02810Y-250.0280.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shanghai Yizhong Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Yizhong Pharmaceutical Co Ltd:

  • The EOD is 5.891. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.091. Based on the equity, the company is overpriced. -1
  • The TTM is 5.805. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.891MRQ5.091+0.799
MRQ5.091TTM5.805-0.714
TTM5.805YOY10.901-5.096
TTM5.8055Y7.018-1.212
5Y7.01810Y7.0180.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Income before Tax  30,2195,40535,624-2,15533,469-28,0025,467-6,305-837
Operating Income  25,1395,35030,488-5,03425,454-22,9662,488-9,942-7,454
Tax Provision  3,7059894,694-4034,291-4,155137-1,135-998



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,488,082
Total Liabilities50,898
Total Stockholder Equity1,437,184
 As reported
Total Liabilities 50,898
Total Stockholder Equity+ 1,437,184
Total Assets = 1,488,082

Assets

Total Assets1,488,082
Total Current Assets845,817
Long-term Assets642,265
Total Current Assets
Cash And Cash Equivalents 651,130
Short-term Investments 3,008
Net Receivables 116,846
Inventory 30,181
Other Current Assets 28,767
Total Current Assets  (as reported)845,817
Total Current Assets  (calculated)829,932
+/- 15,885
Long-term Assets
Property Plant Equipment 136,564
Intangible Assets 8,416
Long-term Assets Other 486,946
Long-term Assets  (as reported)642,265
Long-term Assets  (calculated)631,927
+/- 10,338

Liabilities & Shareholders' Equity

Total Current Liabilities46,961
Long-term Liabilities3,938
Total Stockholder Equity1,437,184
Total Current Liabilities
Short Long Term Debt 10,907
Accounts payable 23,499
Total Current Liabilities  (as reported)46,961
Total Current Liabilities  (calculated)34,405
+/- 12,555
Long-term Liabilities
Long-term Liabilities  (as reported)3,938
Long-term Liabilities  (calculated)0
+/- 3,938
Total Stockholder Equity
Retained Earnings 192,465
Total Stockholder Equity (as reported)1,437,184
Total Stockholder Equity (calculated)192,465
+/- 1,244,719
Other
Capital Stock205,760
Common Stock Shares Outstanding 205,760
Net Invested Capital 1,448,091
Net Working Capital 798,857
Property Plant and Equipment Gross 136,564



6.3. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
269,613
0
0
258,810
265,793
260,625
1,194,894
1,200,562
1,216,940
1,250,027
1,329,759
1,354,594
1,418,080
1,451,247
1,516,346
1,573,359
1,615,717
1,535,585
1,488,082
1,488,0821,535,5851,615,7171,573,3591,516,3461,451,2471,418,0801,354,5941,329,7591,250,0271,216,9401,200,5621,194,894260,625265,793258,81000269,613
   > Total Current Assets 
130,757
0
0
57,727
0
61,157
996,629
993,551
1,022,564
1,037,248
1,109,722
1,199,711
1,261,329
1,291,666
1,356,112
1,413,244
1,453,857
912,500
845,817
845,817912,5001,453,8571,413,2441,356,1121,291,6661,261,3291,199,7111,109,7221,037,2481,022,564993,551996,62961,157057,72700130,757
       Cash And Cash Equivalents 
708
0
0
191
0
222
610,493
110,431
286,117
643,402
689,060
710,381
768,132
755,848
809,629
914,763
974,246
267,514
651,130
651,130267,514974,246914,763809,629755,848768,132710,381689,060643,402286,117110,431610,493222019100708
       Short-term Investments 
123,148
0
0
40,658
0
23,540
341,641
832,648
665,762
319,552
346,156
338,897
323,872
324,701
315,880
325,418
305,334
460,708
3,008
3,008460,708305,334325,418315,880324,701323,872338,897346,156319,552665,762832,648341,64123,540040,65800123,148
       Net Receivables 
0
0
0
0
0
0
0
0
17,657
32,377
34,410
42,435
71,138
114,027
133,633
142,981
134,361
138,971
116,846
116,846138,971134,361142,981133,633114,02771,13842,43534,41032,37717,65700000000
       Inventory 
1,698
0
0
1,477
0
1,131
10,886
11,781
16,069
19,955
15,340
17,061
15,912
15,104
25,842
28,406
30,244
30,511
30,181
30,18130,51130,24428,40625,84215,10415,91217,06115,34019,95516,06911,78110,8861,13101,477001,698
       Other Current Assets 
5,203
0
0
15,400
0
36,265
33,609
38,692
10,333
10,528
12,225
80,224
69,875
69,748
59,926
534
2,272
4,992
28,767
28,7674,9922,27253459,92669,74869,87580,22412,22510,52810,33338,69233,60936,265015,400005,203
   > Long-term Assets 
138,855
0
0
201,083
265,793
199,468
198,265
207,011
194,375
212,779
220,037
154,883
156,750
159,582
160,234
160,116
161,861
623,085
642,265
642,265623,085161,861160,116160,234159,582156,750154,883220,037212,779194,375207,011198,265199,468265,793201,08300138,855
       Property Plant Equipment 
88,037
0
0
87,815
0
85,627
83,968
83,949
82,772
94,039
113,832
121,452
120,626
123,079
123,205
120,214
121,399
120,248
136,564
136,564120,248121,399120,214123,205123,079120,626121,452113,83294,03982,77283,94983,96885,627087,8150088,037
       Intangible Assets 
9,389
0
0
9,227
0
9,119
9,065
9,011
8,957
8,903
8,849
8,794
8,740
8,686
8,632
8,578
8,524
8,470
8,416
8,4168,4708,5248,5788,6328,6868,7408,7948,8498,9038,9579,0119,0659,11909,227009,389
       Long-term Assets Other 
41,430
0
0
104,041
265,793
104,722
105,232
107,981
96,399
103,392
90,865
22,571
25,425
22,565
21,996
23,819
23,896
485,651
486,946
486,946485,65123,89623,81921,99622,56525,42522,57190,865103,39296,399107,981105,232104,722265,793104,0410041,430
> Total Liabilities 
9,833
0
0
15,304
27,791
29,345
35,481
25,022
10,656
13,508
50,053
35,415
37,252
57,877
89,048
108,523
116,810
75,519
50,898
50,89875,519116,810108,52389,04857,87737,25235,41550,05313,50810,65625,02235,48129,34527,79115,304009,833
   > Total Current Liabilities 
5,414
0
0
11,511
0
25,789
32,137
21,104
7,683
10,590
47,266
29,864
31,926
52,649
84,187
103,984
112,468
71,300
46,961
46,96171,300112,468103,98484,18752,64931,92629,86447,26610,5907,68321,10432,13725,789011,511005,414
       Short-term Debt 
0
0
0
3,250
0
20,000
20,000
16,750
1,820
0
0
0
0
0
0
0
0
0
0
00000000001,82016,75020,00020,00003,250000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
1,820
0
0
0
0
0
20,100
44,028
53,100
31,019
10,907
10,90731,01953,10044,02820,100000001,82000000000
       Accounts payable 
1,924
0
0
2,198
0
1,118
7,400
1,116
2,484
3,337
35,384
21,534
14,098
32,139
26,621
37,695
40,244
29,653
23,499
23,49929,65340,24437,69526,62132,13914,09821,53435,3843,3372,4841,1167,4001,11802,198001,924
       Other Current Liabilities 
3,089
0
0
5,769
0
4,461
4,319
3,238
3,379
7,253
11,881
1
17,828
13
344
16
0
0
0
000163441317,828111,8817,2533,3793,2384,3194,46105,769003,089
   > Long-term Liabilities 
4,419
0
0
3,792
27,791
3,556
3,344
3,918
2,972
2,918
2,787
5,551
5,326
5,228
4,860
4,539
4,342
4,219
3,938
3,9384,2194,3424,5394,8605,2285,3265,5512,7872,9182,9723,9183,3443,55627,7913,792004,419
> Total Stockholder Equity
259,779
0
0
243,506
238,002
231,280
1,159,413
1,175,540
1,206,284
1,236,519
1,279,706
1,319,178
1,380,828
1,393,371
1,427,299
1,464,837
1,498,908
1,460,066
1,437,184
1,437,1841,460,0661,498,9081,464,8371,427,2991,393,3711,380,8281,319,1781,279,7061,236,5191,206,2841,175,5401,159,413231,280238,002243,50600259,779
   Common Stock
79,350
0
0
79,350
0
79,350
105,800
105,800
105,800
105,800
105,800
0
143,888
0
0
0
0
0
0
000000143,8880105,800105,800105,800105,800105,80079,350079,3500079,350
   Retained Earnings 
-6,291
0
0
-22,564
0
-34,790
-42,688
-26,561
4,183
34,418
77,605
104,647
159,672
165,591
192,105
206,861
236,039
192,304
192,465
192,465192,304236,039206,861192,105165,591159,672104,64777,60534,4184,183-26,561-42,688-34,7900-22,56400-6,291
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
186,720
0
0
186,720
238,002
186,720
1,096,301
1,096,301
1,096,301
1,096,301
1,096,301
0
1,077,267
0
0
0
0
0
0
0000001,077,26701,096,3011,096,3011,096,3011,096,3011,096,301186,720238,002186,72000186,720



6.4. Balance Sheets

Currency in CNY. All numbers in thousands.




6.5. Cash Flows

Currency in CNY. All numbers in thousands.




6.6. Income Statements

Currency in CNY. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue360,254
Cost of Revenue-23,586
Gross Profit336,668336,668
 
Operating Income (+$)
Gross Profit336,668
Operating Expense-193,775
Operating Income166,478142,893
 
Operating Expense (+$)
Research Development22,451
Selling General Administrative101,117
Selling And Marketing Expenses0
Operating Expense193,775123,567
 
Net Interest Income (+$)
Interest Income27,247
Interest Expense-270
Other Finance Cost-52
Net Interest Income26,925
 
Pretax Income (+$)
Operating Income166,478
Net Interest Income26,925
Other Non-Operating Income Expenses0
Income Before Tax (EBT)186,900166,478
EBIT - interestExpense = -270
161,554
161,824
Interest Expense270
Earnings Before Interest and Taxes (EBIT)0187,170
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax186,900
Tax Provision-25,346
Net Income From Continuing Ops161,554161,554
Net Income161,554
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-26,925
 

Technical Analysis of Shanghai Yizhong Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Yizhong Pharmaceutical Co Ltd. The general trend of Shanghai Yizhong Pharmaceutical Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Yizhong Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Yizhong Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 43.68 < 49.24 < 50.76.

The bearish price targets are: 37.38 > 37.00 > 33.34.

Tweet this
Shanghai Yizhong Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Yizhong Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Yizhong Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Yizhong Pharmaceutical Co Ltd. The current macd is 1.12287167.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai Yizhong Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shanghai Yizhong Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shanghai Yizhong Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Yizhong Pharmaceutical Co Ltd. The current adx is 27.88.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shanghai Yizhong Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Shanghai Yizhong Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Yizhong Pharmaceutical Co Ltd. The current sar is 34.64.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Yizhong Pharmaceutical Co Ltd. The current rsi is 67.80. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Yizhong Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Yizhong Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Yizhong Pharmaceutical Co Ltd. The current cci is 117.88.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Yizhong Pharmaceutical Co Ltd. The current cmo is 49.51.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Yizhong Pharmaceutical Co Ltd. The current willr is -20.74688797.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shanghai Yizhong Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shanghai Yizhong Pharmaceutical Co Ltd Daily Williams %R ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Yizhong Pharmaceutical Co Ltd.

Shanghai Yizhong Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Yizhong Pharmaceutical Co Ltd. The current atr is 1.76184274.

Shanghai Yizhong Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Yizhong Pharmaceutical Co Ltd. The current obv is 45,507,108.

Shanghai Yizhong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Yizhong Pharmaceutical Co Ltd. The current mfi is 74.13.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shanghai Yizhong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShanghai Yizhong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Yizhong Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside

6.3. Candlestick Patterns

Shanghai Yizhong Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Yizhong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.804
Ma 20Greater thanMa 5036.809
Ma 50Greater thanMa 10037.421
Ma 100Greater thanMa 20039.053
OpenGreater thanClose41.140
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shanghai Yizhong Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Yizhong Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Yizhong Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Yizhong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shanghai Yizhong Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Yizhong Pharmaceutical Co Ltd.

Receive notifications about Shanghai Yizhong Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.